Measurement of cytokines and adhesion molecules in the first 72 hours after severe trauma: Association with severity and outcome

Disease Markers

Volumn 2015, Issue , 2015, Pages

  Sousa, António ^a,b   Raposo, Frederico ^c   Fonseca, Sara ^c   Valente, Luís ^c   Duarte, Filipe ^c   Gonçalves, Moura ^a   Tuna, Diana ^a   Paiva, José Artur ^a,d  

^a Centro Hospitalar Universitário de São João   (Portugal)

^b Orthopaedic Department Emergency and Intensive Care Department   (Portugal)

^c CHSJ Anesthesiology Department   (Portugal)

^d University of Porto   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE;

ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; BLOOD SAMPLING; COHORT ANALYSIS; CYTOKINE RELEASE; FEMALE; HOSPITAL ADMISSION; HUMAN; INJURY SCALE; INJURY SEVERITY; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MULTIPLE ORGAN FAILURE; MULTIPLE TRAUMA; OUTCOME ASSESSMENT; PERFUSION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SHOCK; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TH1 TH2 BALANCE; ADOLESCENT; ADULT; BLOOD; COMPLICATION; EMERGENCY HEALTH SERVICE; INJURY; MIDDLE AGED; RESPIRATORY DISTRESS SYNDROME, ADULT; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME;

ADOLESCENT; ADULT; CYTOKINES; FEMALE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MALE; MIDDLE AGED; RESPIRATORY DISTRESS SYNDROME, ADULT; TH1-TH2 BALANCE; TRAUMA CENTERS; TRAUMA SEVERITY INDICES; TREATMENT OUTCOME; WOUNDS AND INJURIES;

EID: 84925638644     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.1155/2015/747036     Document Type: Article

References (24)

1. F. Lecky, M. Woodford, and D.W. Yates, "Trends in trauma care in England and Wales 1989-97," The Lancet, vol. 355, no. 9217, pp. 1771-1775, 2000.
2. B. Mitra, F. Tullio, P. A. Cameron, and M. Fitzgerald, "Trauma patients with the 'triad of death'," Emergency Medicine Journal, vol. 29, no. 8, pp. 622-625, 2012.
3. R. A. Cherry, T. S. King, D. E. Carney, P. Bryant, and R. N. Cooney, "Trauma team activation and the impact onmortality," Journal of Trauma - Injury, Infection and Critical Care, vol. 63, no. 2, pp. 326-330, 2007.
4. R. C. Bone, "Immunologic dissonance: a continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and themultiple organ dysfunction syndrome (MODS)," Annals of Internal Medicine, vol. 125, no. 8, pp. 680-687, 1996.
5. W. Xiao, M. N. Mindrinos, J. Seok et al., "A genomic storm in critically injured humans," Journal of Experimental Medicine, vol. 208, no. 13, pp. 2581-2590, 2011.
6. P. V. Giannoudis, F. Hildebrand, and H. C. Pape, "Inflammatory serum markers in patients with multiple trauma. Can they predict outcome?" The Journal of Bone and Joint Surgery - British Volume, vol. 86, no. 3, pp. 313-323, 2004.
7. M. J. Cohen, K. Brohi, C. S. Calfee et al., "Early release of high mobility group box nuclear protein 1 after severe trauma in humans: role of injury severity and tissue hypoperfusion," Critical Care, vol. 13, no. 6, article R174, 2009.
8. H. Iwasaka and T. Noguchi, "Th1/Th2 balance in systemic inflammatory response syndrome (SIRS)," Nippon Rinsho, vol. 62, no. 12, pp. 2237-2243, 2004.
9. "American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis," Critical Care Medicine, vol. 20, no. 6, pp. 864-874, 1992.
10. A. Lenz, G. A. Franklin, and W. G. Cheadle, "Systemic inflammation after trauma," Injury, vol. 38, no. 12, pp. 1336-1345, 2007.
11. J. R. Klune, R. Dhupar, J. Cardinal, T. R. Billiar, and A. Tsung, "HMGB1: endogenous danger signaling," Molecular Medicine, vol. 14, no. 7-8, pp. 476-484, 2008.
12. L. Ulloa and D. Messmer, "High-mobility group box 1 (HMGB1) protein: friend and foe,"Cytokine&Growth Factor Reviews, vol. 17, no. 3, pp. 189-201, 2006.
13. P. F. Stahel, W. R. Smith, and E. E. Moore, "Role of biological modifiers regulating the immune response after trauma," Injury, vol. 38, no. 12, pp. 1409-1422, 2007.
14. T. Tsukamoto, R. S. Chanthaphavong, and H.-C. Pape, "Current theories on the pathophysiology of multiple organ failure after trauma," Injury, vol. 41, no. 1, pp. 21-26, 2010.
15. C. Martin, C. Boisson, M. Haccoun, L. Thomachot, and J.-L. Mege, "Patterns of cytokine evolution (tumor necrosis factoralpha and interleukin-6) after septic shock, hemorrhagic shock, and severe trauma," Critical Care Medicine, vol. 25, no. 11, pp. 1813-1819, 1997.
16. M. N. Chawda, F. Hildebrand, H. C. Pape, and P. V. Giannoudis, "Predicting outcome after multiple trauma: which scoring system?" Injury, vol. 35, no. 4, pp. 347-358, 2004.
17. P. V. Giannoudis, R. M. Smith, C. W. Ramsden, D. Sharples, R. A. Dickson, and P. J. Guillou, "Molecular mediators and trauma: effects of accidental trauma on the production of plasma elastase, IL-6, sICAM-1, and sE-selectin," Injury, vol. 27, no. 5, p. 372, 1996.
18. F. Gebhard, H. Pfetsch, G. Steinbach, W. Strecker, L. Kinzl, and U. B. Brückner, "Is interleukin 6 an early marker of injury severity following major trauma in humans?" Archives of Surgery, vol. 135, no. 3, pp. 291-295, 2000.
19. H.-C. Pape, M. van Griensven, J. Rice et al., "Major secondary surgery in blunt trauma patients and perioperative cytokine liberation: determination of the clinical relevance of biochemical markers," Journal of Trauma, vol. 50, no. 6, pp. 989-1000, 2001.
20. K. Raymondos, M. U. Martin, T. Schmudlach et al., "Early alveolar and systemic mediator release in patients at different risks for ARDS after multiple trauma," Injury, vol. 43, no. 2, pp. 189-195, 2012.
21. W. Y. Park, R. B. Goodman, K. P. Steinberg et al., "Cytokine balance in the lungs of patients with acute respiratory distress syndrome," The American Journal of Respiratory and Critical Care Medicine, vol. 164, no. 101, pp. 1896-1903, 2001.
22. R. M. Smith, P. V. Giannoudis, M. C. Bellamy, S. L. Perry, R. A. Dickson, and P. J. Guillou, "Interleukin-10 release and monocyte human leukocyte antigen-DR expression during femoral nailing," Clinical Orthopaedics & Related Research, vol. 373, pp. 233-240, 2000.
23. M. M. Law, H. G. Cryer, E. Abraham et al., "Elevated levels of soluble ICAM-1 correlate with the development of multiple organ failure in severely injured trauma patients," Journal of Trauma, vol. 37, no. 1, pp. 100-110, 1994.
24. A. Cheron, B. Floccard, B. Allaouchiche et al., "Lack of recovery in monocyte human leukocyte antigen-DR expression is independently associated with the development of sepsis aftermajor trauma," Critical Care, vol. 14, no. 6, article R208, 2010.